Ftse Mib
33.986,90
1,06%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.113,45
-0,08%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TransMedics Group Inc (TMDX) TransMedics Group Inc (TMDX) Notizie

TransMedics Group Inc

TMDX
130,40
2,41 (1,88%)
07 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/5/202400:08EDGAR2Form 144 - Report of proposed sale of securities
06/5/202416:54EDGAR2Form 144 - Report of proposed sale of securities
30/4/202422:05PRNUSTransMedics Reports First Quarter 2024 Financial Results
16/4/202422:05PRNUSTransMedics to Report First Quarter 2024 Financial Results..
08/4/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
19/3/202421:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
06/3/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202420:23EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:06PRNUSTransMedics to Present at Upcoming March Investor..
28/2/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202422:19EDGAR2Form 8-K - Current report
26/2/202422:05PRNUSTransMedics Reports Fourth Quarter and Full Year 2023..
26/2/202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
16/2/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
12/2/202422:05PRNUSTransMedics to Report Fourth Quarter and Full Year 2023..
08/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:05EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:05EDGAR2Form 8-K - Current report
03/2/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202417:05EDGAR2Form 144 - Report of proposed sale of securities
29/1/202422:05EDGAR2Form 8-K - Current report
29/1/202421:50BWNew Innovation-Themed Whitepaper to Debut at the February..
22/1/202416:30BWInvestment Opportunities in the Innovation Economy Headline..
16/1/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
03/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:05EDGAR2Form 8-K - Current report
02/1/202417:46EDGAR2Form 144 - Report of proposed sale of securities
19/12/202322:14EDGAR2Form 8-K - Current report
18/12/202322:05PRNUSTransMedics to Participate in the 42nd Annual J.P. Morgan..
15/12/202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202323:47EDGAR2Form 144 - Report of proposed sale of securities
12/12/202322:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
21/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202322:05PRNUSTransMedics to Present at the Piper Sandler 35th Annual..
08/11/202322:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202312:33IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
06/11/202322:23EDGAR2Form 8-K - Current report
06/11/202322:05PRNUSTransMedics Reports Third Quarter 2023 Financial Results
03/11/202321:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
23/10/202322:05PRNUSTransMedics to Report Third Quarter 2023 Financial Results..
10/10/202322:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
04/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202316:23EDGAR2Form 144 - Report of proposed sale of securities
22/9/202322:30EDGAR2Form 8-K - Current report
12/9/202322:09EDGAR2Form 8-K - Current report
05/9/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:25EDGAR2Form 8-K - Current report
Apertura: 128,70 Min: 125,65 Max: 132,85
Chiusura: 127,99

La tua Cronologia

NASDAQ
TMDX
TransMedics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network